News from keystone heart ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 29, 2020, 08:01 ET Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, today announced completion of the first...

Jun 16, 2020, 08:01 ET Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, today announced it has acquired 510...

Mar 10, 2020, 08:11 ET TriGUARD 3™ Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures

Keystone Heart Ltd., a Venus Medtech Company, today announced European CE Mark for the TriGUARD 3™ Cerebral Embolic Protection (CEP) Device. The...

Jul 11, 2019, 08:34 ET Keystone Heart Ltd. and Vasorum Ltd. enter distribution agreement for Celt ACD® Vascular Closure Device

Keystone Heart Ltd. today announced that it has signed a distribution agreement with Ireland-based Vasorum Ltd. for sales and marketing of their Celt ...

Dec 26, 2018, 12:22 ET Venus Medtech Completes Merger with Keystone Heart, Ltd.

Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has closed its Merger with Keystone Heart ...

Sep 25, 2018, 07:31 ET Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has signed an agreement to acquire...

May 31, 2018, 12:07 ET Keystone Heart Ltd Announces First Enrollment in REFLECT Phase II incorporating TriGUARD 3™ Cerebral Embolic Protection device

Keystone Heart Ltd., the leading medical device company focused on providing complete cerebral protection for patients undergoing cardiac procedures, ...

Aug 01, 2017, 13:06 ET Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients undergoing cardiac procedures, ...

Mar 02, 2017, 11:06 ET Keystone Heart und Venus Medtech erklären Zusammenarbeit beim Schutz vor Hirnembolie mit Transkatheter-Herzklappensystemen (TAVR) in China und asiatischen Schlüsselmärkten

Keystone Heart Ltd., ein Medizinprodukteunternehmen, das auf die Entwicklung von Hirnembolie-Schutzsystemen für Herzeingriffe spezialisiert ist, und...

Mar 02, 2017, 07:17 ET Keystone Heart and Venus Medtech Announce Partnership for Cerebral Embolic Protection with Transcatheter Heart Valve Systems (TAVR) in China and Key Asian Markets

Keystone Heart Ltd., a medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures,...

Feb 27, 2017, 07:17 ET Keystone Heart Applauds FDA Advisory Panel for Recognition of The Need for Cerebral Protection Following TAVR

Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac...

Oct 03, 2016, 09:52 ET American Journal of Cardiology Reports Data Showing New Brain Lesions in 94% of Patients Following TAVR

Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients undergoing cardiovascular...

Sep 19, 2016, 11:34 ET TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in Brain Protection in Patients Undergoing TAVR Procedures

Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients undergoing cardiac procedures, ...

Mar 17, 2015, 11:00 ET Los datos presentados en el ACC demuestran los beneficios del dispositivo de protección cerebral TriGuard™ de Keystone Heart durante el TAVR

Los ensayos más recientes en el Colegio estadounidense de cardiología (ACC, por sus siglas en inglés) incluyen los datos del primer ensayo clínico...

Mar 17, 2015, 08:00 ET Dados apresentados no ACC demonstram benefícios do dispositivo de proteção cerebral TriGuard™ da Keystone Heart durante TAVR

Os últimos ensaios anunciados no ACC incluem os dados do primeiro ensaio clínico randomizado e multicêntrico, DEFLECT III, testando o TriGuard...

Mar 17, 2015, 05:46 ET Los datos demuestran los beneficios del dispositivo de protección cerebral TriGuard™ de Keystone Heart durante TAVR

- Los datos presentados en el ACC demuestran los beneficios del dispositivo de protección cerebral TriGuard™ de Keystone Heart durante TAVR Sesión...

Mar 16, 2015, 07:49 ET Les données présentées à l'ACC démontrent les avantages du dispositif de protection cérébrale TriGuard™ de Keystone Heart lors des interventions TAVI

Session scientifique annuelle du Collège américain de cardiologie (American College of Cardiology, ACC) Les récents essais à l'ACC incluent les...

Mar 16, 2015, 07:48 ET Bei der ACC vorgestellte Daten zeigen Vorteile der Gehirnschutzvorrichtung TriGuard ™ von Keystone Heart während TAVR

Jährliche wissenschaftliche Sitzung des American College of Cardiology (Amerikanische Hochschule für Kardiologie, ACC) Jüngste bahnbrechende Studien...

Mar 15, 2015, 05:15 ET Data Presented at ACC Demonstrates Benefits of Keystone Heart's TriGuard™ Cerebral Protection Device During TAVR

American College of Cardiology (ACC) Annual Scientific Session -- March 15 2015/PRNewswire/-- Late breaking trials at the ACC include the data from...

Apr 25, 2012, 03:39 ET TAVI Accessory Developer SMT R&D LTD Attracts Seasoned Team, Including CEO, CFO and CMO, Changes Name to Keystone Heart Ltd.

SMT Research & Development, Ltd. ("SMT") today announced the addition of three key executives to its management team, including a new CEO, CFO and...